Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective.
- DOI
- 10.2147/ceor.s625089
- Published
- 2026
- Container
- ClinicoEconomics and outcomes research : CEOR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/ceor.s625089,
title = {Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective.},
author = {Bentham JR and Neervoort J and Louwsma T and Wolters LF and Lyon J and Landaas EJ and Nakum M},
year = {2026},
journal = {ClinicoEconomics and outcomes research : CEOR},
doi = {10.2147/ceor.s625089},
url = {https://doi.org/10.2147/ceor.s625089}
}RIS
TY - JOUR TI - Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective. AU - Bentham JR AU - Neervoort J AU - Louwsma T AU - Wolters LF AU - Lyon J AU - Landaas EJ AU - Nakum M PY - 2026 JO - ClinicoEconomics and outcomes research : CEOR DO - 10.2147/ceor.s625089 UR - https://doi.org/10.2147/ceor.s625089 ER -
APA
JR, B., J, N., T, L., LF, W., J, L., EJ, L., & M, N. (2026). Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective.. ClinicoEconomics and outcomes research : CEOR. https://doi.org/10.2147/ceor.s625089
Source records
- pubmed · retrieved 2026-09-24T21:45:01.174Z
- europe-pmc · retrieved 2026-09-24T21:45:01.182Z